Clinical trial

A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)

NCT05119569

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Fenebrutinib Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-03-01

PhasePHASE2

Conditions

Relapsing Multiple Sclerosisunresolved

Interventions

FenebrutinibDRUG

PlaceboDRUG

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

BelgradeSerbia2 ZagrebCroatia2 Las VegasNevada, United States1 PragueCzechia1 BrnoCzechia1 BratislavaSlovakia1 FullertonCalifornia, United States1 Hradec KrálovéCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05119569 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.